FDA Inspection 961300 — Dendreon Pharmaceuticals LLC
The FDA completed an inspection of Dendreon Pharmaceuticals LLC on January 22, 2016 in Seal Beach, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 22, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Seal Beach, CA (United States)